Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Lobular carcinoma in situ

Afonso, Neliaa; Bouwman, Davidb

European Journal of Cancer Prevention: August 2008 - Volume 17 - Issue 4 - p 312-316
doi: 10.1097/CEJ.0b013e3282f75e5d

The diagnosis of lobular carcinoma in situ (LCIS) provokes considerable anxiety in patients owing to misconceptions about this diagnosis. Initially LCIS was considered a premalignant lesion, but it is now a marker of increased risk. The number of women diagnosed with LCIS has increased in recent years most likely owing to more rigorous breast cancer screening. Implications of this diagnosis and management options are discussed in this review.

Departments of aMedicine

bSurgery, Wayne State University School of Medicine, Alexander J. Walt Comprehensive Breast Center, Karmanos Cancer Institute, Detroit, Michigan, USA

Correspondence to Nelia Afonso, MD, Department of Internal Medicine, 5C-WSU Health Center, 4201 St Antoine, Detroit, MI 48201-2153, USA

Tel: +31 3577 5030; fax: +31 3745 4707;


Received 20 March 2007 Accepted 29 August 2007

© 2008 Lippincott Williams & Wilkins, Inc.